14.96
price down icon4.77%   -0.75
after-market 시간 외 거래: 14.58 -0.38 -2.54%
loading
전일 마감가:
$15.71
열려 있는:
$15.53
하루 거래량:
554.14K
Relative Volume:
0.35
시가총액:
$111.08M
수익:
-
순이익/손실:
$-121.02M
주가수익비율:
-1.3286
EPS:
-11.26
순현금흐름:
$-114.09M
1주 성능:
-7.37%
1개월 성능:
-35.04%
6개월 성능:
-21.22%
1년 성능:
-97.08%
1일 변동 폭
Value
$14.33
$15.57
1주일 범위
Value
$14.33
$17.20
52주 변동 폭
Value
$7.31
$672.00

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Company Profile

Name
명칭
Tonix Pharmaceuticals Holding Corp
Name
전화
212-980-9155
Name
주소
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
직원
81
Name
트위터
@TONIXPharma
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
TNXP's Discussions on Twitter

TNXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
14.96 111.08M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-04-18 개시 Noble Capital Markets Outperform
2019-04-18 업그레이드 ROTH Capital Neutral → Buy
2017-08-18 업그레이드 ROTH Capital Neutral → Buy
2016-09-07 다운그레이드 ROTH Capital Buy → Neutral
2016-02-17 재확인 Oppenheimer Outperform
2015-11-04 개시 Cantor Fitzgerald Buy
2015-06-12 개시 Oppenheimer Outperform
2015-02-17 재확인 ROTH Capital Buy
2014-09-29 재확인 ROTH Capital Buy
모두보기

토닉스 파마슈티컬스 홀딩 주식(TNXP)의 최신 뉴스

pulisher
Apr 16, 2025

Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025 - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Major Breakthrough: Tonix Unveils Single-Dose Mpox Vaccine Data at Leading Global Conference - Stock Titan

Apr 16, 2025
pulisher
Apr 12, 2025

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday? - MSN

Apr 12, 2025
pulisher
Apr 09, 2025

Tonix and Makana partner on xenotransplantation research By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce Collabora - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix and Makana partner on xenotransplantation research - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix'S Anti-Cd40l Monoclonal Antibody (Tnx-1500) With Makana'S Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies - marketscreener.com

Apr 09, 2025
pulisher
Apr 09, 2025

Revolutionary Xenotransplantation Breakthrough: Tonix and Makana Join Forces to Combat Organ Failure - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management - Proactive financial news

Apr 08, 2025
pulisher
Apr 07, 2025

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Game-Changing Fibromyalgia Treatment Achieves Phase 3 Success, FDA Decision Looms - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

(TNXP) Investment Analysis - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 04, 2025

Peering Into Tonix Pharmaceuticals's Recent Short Interest - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

TNXP: No AdCom Required for TNX-102 SL NDA… - Yahoo Finance

Apr 03, 2025
pulisher
Apr 02, 2025

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Tonix Pharmaceuticals Reveals 5 Major Catalysts: FDA Decision, DoD Contract, and Breakthrough Therapies - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Game-Changing Digital Platform Transforms How Patients Track and Treat Migraines - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Lat - PharmiWeb.com

Mar 31, 2025
pulisher
Mar 31, 2025

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 29, 2025

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc. - Bluefield Daily Telegraph

Mar 29, 2025
pulisher
Mar 27, 2025

(TNXP) Long Term Investment Analysis - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Fast-Tracked Fibromyalgia Treatment: Tonix Showcases Breakthrough Pain Drug Data Before FDA Decision - StockTitan

Mar 27, 2025
pulisher
Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha

Mar 26, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic (TNXP) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharma’s TNX-102 SL Advances in FDA Process - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Announces that FDA Will Not Require - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

First New Fibromyalgia Treatment in 15 Years Advances: FDA Expedites TNX-102 SL Review - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling Bullish - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread - BioSpace

Mar 21, 2025

토닉스 파마슈티컬스 홀딩 (TNXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):